Triamterene and Hydrochlorothiazide
- Product NDC
- 10135-581
- 11-digit product format
- 101350581
- Labeler code
- 10135
- Product ID
- 10135-581_d6121404-16a8-4270-919d-97bed516e72b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals Inc
- Application
- ANDA201407
- Marketing category
- ANDA
- Marketing start
- 2014-10-01
- Marketing end
- 0000-00-00
- Substance
- TRIAMTERENE; HYDROCHLOROTHIAZIDE
- Active strength
- 38 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-581-01 | Triamterene and Hydrochlorothiazide | 100 in 1 BOTTLE | CAPSULE | 100 | | 3 |
| 10135-581-10 | Triamterene and Hydrochlorothiazide | 1000 in 1 BOTTLE | CAPSULE | 1000 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-581 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE CAPSULE [MARLEX PHARMACEUTICALS INC] | 3 | Legacy NDC, 2 package rows | 20191213_0cf90605-e7b7-42b4-a0ee-80639b3bcdeb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10135-581-01 | 10135058101 | 100 in 1 BOTTLE | Historical |
| 10135-581-10 | 10135058110 | 1000 in 1 BOTTLE | Historical |